This excerpt taken from the MDT 8-K filed Feb 16, 2005.
Spinal/ENT and Surgical Navigation Businesses
Spinal/Ear, Nose and Throat (ENT) and Surgical Navigation reported revenues of $535.6 million for the quarter, representing a 23-percent increase over the same period in the prior year. Spinal revenues increased 24 percent, ENT revenues grew 14 percent, and Surgical Navigation revenues increased 52 percent. Quarterly highlights included:
The CATALYST Anterior Instrument Set, designed to enable surgeons to more accurately place spinal implants using an anterior surgical approach, and the CAPSTONE Vertebral Body Spacer product line were commercially released in the United States.
Full product launches took place in dynamic stabilization markets outside the United States, led by the DIAM Spinal Stabilization System, PRESTIGE Cervical Disc System, BRYAN® Cervical Disc System and MAVERICK Lumbar Artificial Disc. Clinical trials for the three artificial discs remain on course in the United States.
Medtronic announced a licensing agreement with Purdue University that grants the company exclusive rights to patented technology that utilizes polyethylene glycol to treat acute spinal cord injuries.
The XPSÒ Power Microdebrider System to facilitate sinus surgery and the VISAOÔ Neurototology Drill System were launched in the United States.
The StealthNavigatorÔ was introduced in the United States, providing a complete service package for computer-assisted surgery.
In the fourth quarter, the CD HORIZONÒ LEGACYÔ 6.35, the newest addition to the companys CD HORIZON Spinal System, is also expected to be introduced. The Spinal business also should continue to benefit from the full launches of many products introduced earlier in fiscal 2005, including additions to its Minimal Access Spinal Technologies (MAST) product line.